Abstract Objective To assess the impact of using the left ventricular lead pacing technique in transcatheter aortic valve replacement (TAVR)
Surgical valve technologies Transcatheter heart valves technologies
Abstract Objective To assess the impact of using the left ventricular lead pacing technique in transcatheter aortic valve replacement (TAVR)
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Severe aortic stenosis (AS) significantly impacts patients’ quality of life (QoL). Although transcatheter aortic valve replacement (TAVR) has
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve implantation-in-transcatheter aortic valve implantation represents a progressive solution for patients with degenerated transcatheter heart valves,
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Transcatheter aortic valve replacement (TAVR) is routinely performed under general anesthesia (GA) or sedation. However, there were few
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Post-operative moderate-to-severe mitral regurgitation (MR) following transcatheter aortic valve replacement (TAVR) is associated with poor outcomes, yet the
Surgical valve technologies Transcatheter heart valves technologies
Abstract Background Acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI) is associated with significantly worse outcomes, leading to
Transcatheter heart valves technologies
Abstract Background The prevalence of aortic valve stenosis is on the rise, primarily due to an aging population. Transcatheter
Transcatheter heart valves technologies
Abstract Background New-onset postoperative atrial fibrillation (POAF) is common after transcatheter aortic valve replacement (TAVR). At present, the impact of
Transcatheter heart valves technologies
Abstract Background Right ventricular (RV) function assessment by echocardiography can be challenging due to its complex morphology. Also, increasing use
Transcatheter heart valves technologies
Abstract Background Glycemic control is critical for managing transcatheter aortic valve replacement (TAVR) patients, especially those in intensive care units